Download PDF
Semin Thromb Hemost 2021; 47(06): e1-e2
DOI: 10.1055/s-0042-1757330
Erratum

Erratum: Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis

Jesus Aibar
1   Department of Internal Medicine, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain
2   Department of Medicine, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada
,
Sam Schulman
2   Department of Medicine, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada
3   Department of Obstetrics and Gynecology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia
› Author Affiliations
› Further Information
   Permissions and Reprints

Correction to:

Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-AnalysisSemin Thromb Hemost 2021; 47(06): 709-723
DOI: 10.1055/s-0041-1725057

It has been brought to the publisher's attention that [Fig. 4] published in the above article in Seminars In Thrombosis And Hemostasis, Volume 47, Number 6 (DOI: 10.1055/S-0041-1725057) is incorrect. The corrected figure appears as follows and is placed below.

Zoom Image
Fig. 4 Forest plots of arterial thrombosis. Comparisons between single antiplatelet therapy (SAPT) versus vitamin K antagonist (VKA) (A), dual antiplatelet therapy (DAPT) versus SAPT (B), VKA plus SAPT versus SAPT (C), VKA plus SAPT versus VKA (D), VKA international normalized ratio (INR) 2–3 versus VKA INR 3–4 (E), DAPT versus VKA plus SAPT (F), VKA versus non-VKA oral anticoagulant (NOAC) (G).


Publication History

Article published online:
07 October 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA